Stanford University


Showing 81-94 of 94 Results

  • Jean Y. Tang MD PhD

    Jean Y. Tang MD PhD

    Professor of Dermatology

    Current Research and Scholarly InterestsMy research focuses on 2 main areas:

    1. Skin cancer:
    - New therapeutics to treat and prevent non-melanoma skin cancer, especially by targeting the Hedgehog signaling pathway for BCC tumors
    - Genomic analysis of drug-resistant cancers
    - Identifying risk factors for skin cancer in the Women's Health Initiative

    2. Epidermolysis Bullosa: gene therapy and protein therapy to replace defective/absent Collagen 7 in children and adults with Recessive Dystrophic EB

  • Joyce Teng, MD, PhD

    Joyce Teng, MD, PhD

    Professor of Dermatology and, by courtesy, of Pediatrics

    BioJoyce Teng, MD, PhD is a professor in dermatology at Stanford University. She is affiliated with multiple hospitals in the area, including Lucile Salter Packard Children's Hospital (LPCH) at Stanford and Stanford Hospital and Clinics (SHC). She received her medical degree from Vanderbilt University School of Medicine and has been in practice for more than 12 years. She is one of the 6 pediatric dermatologists practicing at LPCH and one of 72 at SHC who specialize in Dermatology. She sees patients with rare genetic disorders, birthmarks, vascular anomalies and a variety of inflammatory skin diseases. She is also an experienced pediatric dermatological surgeon. Her research interests are drug discovery and novel therapy for skin disorders.

  • Jennifer Y. Wang, MD

    Jennifer Y. Wang, MD

    Clinical Assistant Professor, Dermatology

    BioDr. Wang is a board-certified dermatologist. She is a Clinical Assistant Professor of Dermatology at Stanford University School of Medicine. Dr. Wang is also board-certified in dermatopathology.

    Her clinical interests include medical dermatology and cutaneous oncology, including melanoma, high-risk skin cancer, and cutaneous lymphoma. Her research interests include the histopathologic characterization of rare skin disorders and improving the detection and treatment of skin cancers.

  • Wen-Kai Weng, MD, PhD

    Wen-Kai Weng, MD, PhD

    Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy) and, by courtesy, of Dermatology

    Current Research and Scholarly InterestsMy research interest is on immunotherapy (including allogeneic transplant) of cancer. I have studies the mechanism of monoclonal antibody therapy in lymphoma patients and am currently working on designing new strategy to enhance the clinical efficacy of antibody therapy by infusing expanded NK cells. I am also interested in using tumor vaccine along with hematopoietic cell transplant.

  • Carl Gustaf Winge,MD PhD

    Carl Gustaf Winge,MD PhD

    Clinical Instructor, Dermatology

    BioMårten Winge, M.D. Ph.D., is a Clinical Instructor of Dermatology and conducts research in the laboratory of Dr Paul Khavari at Stanford, where he studies epidermal differentiation. Dr Winge completed his M.D. and Ph.D studies at Karolinska Institute in Sweden, and subsequently a research fellowship followed by dermatology residency at Stanford. His clinical interests include inflammatory skin disease as well as skin cancer.

  • David J. Wong, MD, PhD

    David J. Wong, MD, PhD

    Clinical Associate Professor, Dermatology

    Current Research and Scholarly InterestsMy research interest is focused on investigating the molecular networks that underlie cancer stem cells and designing therapies that selectively target these cells, thereby eliminating a cancer's potential for regrowth.

  • Caely Hambro Yanikoglu, MD

    Caely Hambro Yanikoglu, MD

    Clinical Assistant Professor, Dermatology

    BioDr. Caely Yanikoglu is a Clinical Assistant Professor of Dermatology at Stanford. Dr. Yanikoglu received her Bachelor of Science degree with distinction from the University of Michigan. She received her medical degree from Columbia University in New York, where she was inducted into the Alpha Omega Alpha honor society. She completed her residency in dermatology at Stanford University Medical Center and served as chief resident in her final year. Dr. Yanikoglu’s clinical interest is general medical dermatology, including skin cancer, acne, psoriasis, atopic dermatitis, and dermatologic surgery.

  • Jennifer Elynn Yeh, MD PhD

    Jennifer Elynn Yeh, MD PhD

    Clinical Assistant Professor, Dermatology

    BioDr. Jennifer E. Yeh, M.D. Ph.D., is a Clinical Assistant Professor of Dermatology at Stanford University School of Medicine. Dr. Yeh graduated Phi Beta Kappa and Tau Beta Pi with a B.S. in chemical & biological engineering from the Massachusetts Institute of Technology. She received her M.D. and Ph.D. from Harvard Medical School, where she studied molecular modulators of the oncogenic transcription factor STAT3 and received the Ruth L. Kirschstein National Research Service Award from the National Cancer Institute. She completed her internship in internal medicine at Brigham and Women’s Hospital followed by Dermatology residency in the Harvard Combined Dermatology Program where she served as Chief Resident during her final year.

    Dr. Yeh co-directs a Dermatology-Rheumatology multidisciplinary clinic with a focus on autoimmune connective tissue diseases with Dr. Yashaar Chaichian (Rheumatology). Her clinical interests also include acne, eczema, psoriasis, and skin cancer. She has a special interest in medical education and serves as Co-Director of the Medical Dermatology curriculum for the Stanford Dermatology Residency Program. She also serves as the department's Wellbeing Director, championing initiatives to enhance professional fulfillment and reduce burnout.

  • Lisa Zaba, MD, PhD

    Lisa Zaba, MD, PhD

    Associate Professor of Dermatology

    BioLisa Zaba M.D. Ph.D., is an Associate Professor of Dermatology, and Director of the Merkel cell carcinoma (MCC) multi-disciplinary clinic and member of the supportive oncodermatology group at the Stanford Cancer Center. She runs a lab focusing on the immunology of MCC and the treatment and prognostic implications of immune checkpoint inhibitor and targeted therapy rashes. Dr. Zaba completed medical school at Cornell University, PhD in immunology at Rockefeller University, Residency and Post-Doc at Stanford University in 2013.